Related Experiment Video

Updated: Jul 6, 2026

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

Metastatic brain lesions may demonstrate photopenia on FDG-PET

Yiyan Liu1

  • 1Department of Radiology, Nuclear Medicine Service, University Hospital, UMDNJ, Newark, New Jersey 07103, USA. liuyl@umdnj.edu

Clinical Nuclear Medicine
|March 22, 2008
PubMed

Insights

Metastatic brain lesions typically appear as hypermetabolic foci on FDG-PET scans. However, this study presents rare cases where lung cancer metastases showed complete photopenia, challenging typical interpretations.

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Neurology

Background:

  • Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) is commonly used to detect metastatic brain lesions, which usually appear as hypermetabolic foci.
  • A significant area of reduced uptake (photopenia) on FDG-PET brain scans is generally indicative of a benign cause.

Observation:

  • This report details two instances of cerebral metastases originating from lung cancer that exhibited complete photopenia on FDG-PET imaging.
  • The brain's unique physiology, including high background uptake and cytotoxic edema around metastases, can complicate the identification of malignant intracranial lesions on PET scans.

Findings:

  • Lung cancer metastases can present as areas of photopenia on FDG-PET, contrary to the typical hypermetabolic presentation.
  • The interpretation of intracranial FDG-PET findings requires careful consideration of potential pitfalls.

Implications:

  • These findings highlight the necessity of correlating FDG-PET imaging with anatomical modalities like MRI or CT for accurate diagnosis of brain metastases.
  • Rethinking the diagnostic criteria for brain metastases on FDG-PET may be warranted in specific oncological contexts.

More Related Videos

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia10:35

Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia

Published on: September 20, 2015

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET